Group One Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-389,200
Closed -$1.9M 7951
2025
Q1
$1.9M Buy
389,200
+272,600
+234% +$1.64M 0.01% 1858
2024
Q4
$972K Buy
116,600
+106,900
+1,102% +$934K ﹤0.01% 2601
2024
Q3
$101K Sell
9,700
-14,690
-60% -$244K ﹤0.01% 4169
2024
Q2
$480K Buy
24,390
+1,115
+5% +$22.3K ﹤0.01% 2600
2024
Q1
$596K Sell
23,275
-40,150
-63% -$1.03M ﹤0.01% 2561
2023
Q4
$1.75M Buy
63,425
+29,505
+87% +$1.8M ﹤0.01% 1980
2023
Q3
$2.06M Sell
33,920
-450
-1% -$31.6K 0.01% 1620
2023
Q2
$2.26M Buy
34,370
+32,875
+2,199% +$2.41M 0.01% 1595
2023
Q1
$95.1K Buy
1,495
+585
+64% +$66.8K ﹤0.01% 4344
2022
Q4
$126K Sell
910
-8,640
-90% -$1.22M ﹤0.01% 4230
2022
Q3
$1.21M Buy
9,550
+4,625
+94% +$523K ﹤0.01% 2378
2022
Q2
$408K Buy
4,925
+1,580
+47% +$123K ﹤0.01% 3617
2022
Q1
$324K Sell
3,345
-7,835
-70% -$1.03M ﹤0.01% 4288
2021
Q4
$2.23M Sell
11,180
-9,425
-46% -$2.22M ﹤0.01% 2481
2021
Q3
$5.1M Buy
20,605
+2,679
+15% +$766K 0.01% 1663
2021
Q2
$7.43M Buy
17,926
+363
+2% +$144K 0.01% 1332
2021
Q1
$6.86M Buy
17,563
+8,531
+94% +$4.2M 0.01% 1238
2020
Q4
$5.06M Buy
9,032
+1,158
+15% +$734K 0.01% 1268
2020
Q3
$5.5M Sell
7,874
-742
-9% -$579K 0.02% 858
2020
Q2
$6.81M Sell
8,616
-3,080
-26% -$2.32M 0.03% 612
2020
Q1
$6.96M Buy
11,696
+6,910
+144% +$6.73M 0.06% 387
2019
Q4
$5.44M Buy
4,786
+2,277
+91% +$2.48M 0.04% 634
2019
Q3
$2.98M Sell
2,509
-5,396
-68% -$8.24M 0.02% 910
2019
Q2
$13M Buy
7,905
+4,601
+139% +$7.96M 0.12% 172
2019
Q1
$6.73M Sell
3,304
-3,798
-53% -$6.69M 0.08% 308
2018
Q4
$9.13M Sell
7,102
-1,027
-13% -$1.58M 0.08% 279
2018
Q3
$15.4M Buy
8,129
+949
+13% +$1.96M 0.12% 165
2018
Q2
$14.6M Buy
7,180
+294
+4% +$670K 0.12% 163
2018
Q1
$15.2M Sell
6,886
-6,516
-49% -$16.6M 0.15% 125
2017
Q4
$30.9M Buy
13,402
+6,554
+96% +$13.3M 0.22% 76
2017
Q3
$12.2M Buy
6,848
+865
+14% +$1.21M 0.11% 204
2017
Q2
$8.14M Sell
5,983
-3,644
-38% -$4.4M 0.08% 275
2017
Q1
$11.3M Sell
9,627
-648
-6% -$661K 0.13% 167
2016
Q4
$8.21M Buy
10,275
+4,616
+82% +$3.67M 0.08% 280
2016
Q3
$4.97M Buy
5,659
+1,598
+39% +$1.16M 0.05% 416
2016
Q2
$2.28M Sell
4,061
-3,211
-44% -$1.82M 0.03% 750
2016
Q1
$4M Buy
7,272
+617
+9% +$379K 0.06% 427
2015
Q4
$5.54M Buy
6,655
+2,571
+63% +$2.57M 0.07% 330
2015
Q3
$4.53M Buy
4,084
+1,498
+58% +$2.73M 0.06% 382
2015
Q2
$5.64M Buy
2,586
+1,034
+67% +$2.11M 0.08% 283
2015
Q1
$2.43M Sell
1,552
-401
-21% -$529K 0.04% 545
2014
Q4
$2.32M Buy
1,953
+100
+5% +$66.8K 0.04% 570
2014
Q3
$861K Buy
1,853
+1,143
+161% +$527K 0.01% 1211
2014
Q2
$355K Buy
710
+401
+130% +$129K 0.01% 1928
2014
Q1
$91K Buy
+309
New +$93.6K ﹤0.01% 3160

Other funds holding BLUE

Group One Trading's BLUE Position: Q2 2025 in Review

Group One Trading sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 21,693 shares — an estimated $106K sold.

Group One Trading first reported a position in BLUE in Q1 2014 and held it in 39 quarters. The position peaked at $8.62M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Group One Trading reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 21,693 bluebird bio shares in Q2 2025, an estimated $106K.
  • Group One Trading first reported a position in bluebird bio in Q1 2014 and held it in 39 quarters.
  • Group One Trading's bluebird bio position peaked at $8.62M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.